1. Shang, Man, Yang, Huijie, Yang, Ran, Yu, Qiujing, Wang, Ting. 2021. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation. In Nature communications, 12, 1940. doi:10.1038/s41467-021-22173-5. https://pubmed.ncbi.nlm.nih.gov/33782411/
2. Zhang, Hao, Zhu, Shuangli, Zhou, Haiting, Xia, Xiaohui, Xiong, Huihua. 2023. Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer. In Frontiers in oncology, 13, 1098357. doi:10.3389/fonc.2023.1098357. https://pubmed.ncbi.nlm.nih.gov/36726381/
3. Chen, Qian, Huang, Peng, Song, Xin-Li, Zhang, Sen-Mao, Qin, Jia-Bi. . [Association of maternal MTHFD1 and MTHFD2 gene polymorphisms with congenital heart disease in offspring]. In Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 24, 797-805. doi:10.7499/j.issn.1008-8830.2203002. https://pubmed.ncbi.nlm.nih.gov/35894196/
4. Pardo-Lorente, Natalia, Gkanogiannis, Anestis, Cozzuto, Luca, Ponomarenko, Julia, Sdelci, Sara. 2024. Nuclear localization of MTHFD2 is required for correct mitosis progression. In Nature communications, 15, 9529. doi:10.1038/s41467-024-51847-z. https://pubmed.ncbi.nlm.nih.gov/39532843/
5. Huang, Jun, Qin, Yinyin, Lin, Canfeng, Huang, Xiaoguang, Zhang, Feiran. 2021. MTHFD2 facilitates breast cancer cell proliferation via the AKT signaling pathway. In Experimental and therapeutic medicine, 22, 703. doi:10.3892/etm.2021.10135. https://pubmed.ncbi.nlm.nih.gov/34007312/
6. Wang, Jie, Yu, Ze, Jiang, Yixiao, Wu, Feiyue, Ma, Haijie. . Downregulation of MTHFD2 Inhibits Proliferation and Enhances Chemosensitivity in Hepatocellular Carcinoma via PI3K/AKT Pathway. In Frontiers in bioscience (Landmark edition), 29, 35. doi:10.31083/j.fbl2901035. https://pubmed.ncbi.nlm.nih.gov/38287824/
智鼠故事 
